ANGLE plc (AIM:CLBX)

Market Cap	7.72M
Revenue (ttm)	2.62M
Net Income (ttm)	-15.78M
Shares Out	321.53M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,455,341
Average Volume	3,931,732
Open	1.900
Previous Close	1.900
Day's Range	1.900 - 2.500
52-Week Range	1.503 - 17.445
Beta	0.08
RSI	47.24
Earnings Date	Dec 10, 2025

About ANGLE

ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1994
• Employees: 119
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CLBX

Financial Performance

In 2024, ANGLE's revenue was 2.86 million, an increase of 30.92% compared to the previous year's 2.19 million. Losses were -14.23 million, -29.34% less than in 2023.